We only have this paper's title and publication details.
Read it at the sourceOpen comparative trial demonstrates tailored eradication matches empirical quadruple therapy with fewer complications in Korean patients, suggesting a safer first-line alternative.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: